Alberta clinicians describe a fragmented response to iron-deficiency anemia in reproductive-aged women
Iron-deficiency anemia in reproductive-aged women is common, yet care often stalls long before treatment is optimized. In Alberta, health care professionals described a system in which diagnosis, follow-up, and durable correction are all vulnerable to delay, inconsistency, or omission—especially for women already facing social or structural disadvantage.
The qualitative study drew on semistructured interviews conducted from March to June 2024 with 13 health care professionals practicing in Alberta, including family physicians, other specialists, and a pharmacist. Their accounts pointed to a care pathway shaped by uneven knowledge, limited resources, and gaps in coordination, with equity-deserving populations bearing a disproportionate share of the consequences.
One clinical pattern stood out quickly: anemia was often treated as a symptom to chase rather than a condition requiring source identification and sustained management.
Knowledge gaps and inconsistent guideline use shape bedside decisions
Across interviews, clinicians described gaps in physician knowledge, skills, and adherence to guidelines as a major obstacle to effective care. Some practitioners overlooked source control, meaning the underlying cause of iron loss or deficiency was not always pursued with enough urgency. In reproductive-aged women, that omission can prolong anemia, delay symptom relief, and leave recurrent deficiency unaddressed.
In practical terms, iron replacement alone is not enough if the driver remains active. Ongoing menstrual blood loss, poor absorption, dietary limitation, inflammation, or other contributing conditions can keep hemoglobin and iron stores from recovering, even when treatment is prescribed. When guideline use is inconsistent, so is the threshold for investigating why the deficiency keeps coming back.
The interviews also pointed to variability in clinical practice across providers and settings. Some clinicians appeared to rely on more standardized approaches, while others faced uncertainty about when to escalate evaluation, how aggressively to monitor response, or how to match treatment intensity to severity and persistence of disease. In a disorder as common as iron-deficiency anemia, that kind of variability can translate into prolonged fatigue, impaired function, and repeated visits without resolution.
Resource constraints make follow-up harder than the prescription itself
Systemic infrastructure and resource limitations formed a second major theme. Clinicians described barriers tied to available appointments, laboratory access, referral pathways, and broader health human resources. Even when a diagnosis was made, the path from recognition to correction was not smooth.
That matters because anemia management is rarely a one-step intervention. It usually requires testing, reassessment, treatment selection, and follow-up to confirm response. If the system cannot support those steps reliably, the burden shifts back to patients, who may already be juggling work, caregiving, transportation, and financial strain.
The study also found fewer facilitators than barriers. That imbalance is clinically important. It suggests that current supports are not yet strong enough to counter the friction built into the care pathway, particularly for patients who need repeated contact with the health system to recover iron stores and avoid relapse.
Patient-centred care is constrained by sexism, suffering, and mistrust
A third theme centered on the difficulty of delivering patient-centred care in a context shaped by biopsychosocial stressors. Clinicians described how sexism and the normalization of suffering can blunt recognition of symptoms and delay treatment. For women with heavy menstrual bleeding, fatigue, dizziness, or reduced exercise tolerance may be normalized for years before a diagnosis is confirmed or pursued seriously.
Biopsychosocial factors also affected access, trust, and adherence. Patients facing poverty, unstable housing, competing responsibilities, or prior negative experiences with the health system may find it harder to attend appointments, complete laboratory testing, or follow through on treatment plans. Trust can erode when symptoms are minimized or when care feels fragmented and repetitive.
The result is not merely inconvenience. It is a clinical pathway in which the same social forces that increase risk also reduce the chance of timely recovery. Equity-deserving groups, in particular, can encounter each layer of delay at once: fewer resources, more barriers to attendance, and a greater likelihood that their symptoms will be discounted.
Weak integration across providers leaves patients to navigate the gaps
Insufficient networking and an integrated care system emerged as the fourth major theme. Clinicians described weak links between professionals and settings, making it harder to coordinate responsibility for diagnosis, treatment, and follow-up. In a condition that often crosses primary care, specialty care, and pharmacy, poor integration is more than an administrative nuisance; it is a clinical hazard.
A fragmented system can leave patients carrying the burden of coordination themselves. They may need to repeat their history, track laboratory results, identify who is responsible for next steps, and decide when symptoms are serious enough to re-present. For a condition that can sap energy and concentration, that is a high burden to place on the patient.
The interviews suggest that stronger networking among professionals could improve recognition and continuity. A connected care model would make it easier to identify recurrent deficiency, standardize escalation, and align treatment plans across disciplines. Without that structure, individual clinicians may work conscientiously while the system still fails to deliver coherent care.
Why the findings point beyond iron pills alone
The interpretation from these interviews is straightforward: barriers to managing iron-deficiency anemia in Alberta arise across patient, clinician, system, and societal levels. The study calls for comprehensive intervention rather than a single fix. Harmonized guidelines could reduce variation in practice. Health care professional education could improve recognition of source control and treatment thresholds. Better health human resources could ease bottlenecks in testing, referral, and follow-up.
The social context also matters. Poverty and other upstream barriers do not disappear with a prescription pad. If access to care is constrained by cost, time, transport, or mistrust, treatment plans that look reasonable on paper may fail in real life. Any serious effort to reduce inequities in anemia care will need to address those external pressures alongside clinical education and system redesign.
This study’s sample was small, but the signal was consistent: clinicians see a condition that is common, persistent, and under-supported by current structures. The most immediate gap is not simply in iron replacement, but in the capacity to diagnose, investigate, coordinate, and follow women until the cause of deficiency is controlled.
A care pathway built to prevent recurrence remains unfinished
The interviews expose a recurring problem in women’s health care: symptoms are treated, but the cycle that produces them is not always broken. When menstrual blood loss, social disadvantage, and fragmented care intersect, iron deficiency can become chronic and underappreciated.
For Alberta clinicians, the challenge is not a lack of awareness alone. It is a health system that still makes comprehensive IDA management difficult for both patients and providers. The next step is not another isolated intervention, but a coordinated response that aligns education, access, and accountability around a condition that should not remain this hard to treat.